Evidence map›Paper›PMID 26517730›Full record

ReviewCurrent opinion in chemical biology2016

Detection and identification of protein citrullination in complex biological systems.

Kathleen W Clancy, Eranthie Weerapana, Paul R Thompson

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Mapping the Substrate Specificity Landscape of PAD2 and PAD4 Enzymes.Chembiochem : a European journal of chemical biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. [Determination of the derivatization reactivity betweenSe pu = Chinese journal of chromatography · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Development of LB244, an Irreversible STING Antagonist.Journal of the American Chemical Society · 2023
    Article
  11. Article
  12. Collision-Induced Dissociation of Citrullinated Peptide Anions.Journal of the American Society for Mass Spectrometry · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. The virtues and vices of protein citrullination.Royal Society open science · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kathleen W ClancyDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 10605, United States; Program in Chemical Biology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 10605, United States; Oncology Discovery Eli Lilly and Company, Indianapolis, IN 46285, United States.
Eranthie WeerapanaDepartment of Chemistry, Boston College, 2609 Beacon St., Chestnut Hill, MA 02467, United States.
Paul R ThompsonDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 10605, United States; Program in Chemical Biology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 10605, United States. Electronic address: paul.thompson@umassmed.edu.
Boston College · US

Funding

Haloacetamidine based inactivators of Protein Arginine Deiminase 4R01GM079357 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI THOMPSON, PAUL R · 2007 to 2016
$3.3M
Identification of Citrullinated Biomarkers of Inflammatory Disease and CancerR01GM110394 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI THOMPSON, PAUL R · 2014 to 2016
$1.7M
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon CancerR01CA151304 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HOFSETH, LORNE J, THOMPSON, PAUL R · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA151304NIGMS NIH HHS GM079357NIGMS NIH HHS GM110394NIGMS NIH HHS R01 GM079357NIGMS NIH HHS R01 GM110394
6 · The paper itself

Abstract

Protein citrullination is a post-translational modification of arginine that is catalyzed by the Protein Arginine Deiminase (PAD) family of enzymes. Aberrantly increased citrullination is associated with a host of inflammatory diseases and cancer and PAD inhibitors have shown remarkable efficacy in a range of diseases including rheumatoid arthritis, lupus, atherosclerosis, and ulcerative colitis. In rheumatoid arthritis, citrullinated proteins serve as key antigens for rheumatoid arthritis-associated autoantibodies. These data suggest that citrullinated proteins may serve more generally as biomarkers of specific disease states, however, the identification of citrullinated residues remains challenging due to the small 1Da mass change that occurs upon citrullination. Herein, we highlight the available techniques to identify citrullinated proteins/residues focusing on advanced MS techniques as well as chemical derivatization strategies that are currently being employed to identify citrullinated proteins as well as the specific residues modified within those proteins.

Indexed as

Protein Processing, Post-TranslationalAnimalsArginineCitrullineHumansMass SpectrometryProteinsArginineCitrullineProteins

Identifiers

PMID26517730
PMCPMC4731267
OpenAlexW1844436823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.